5.835
Schlusskurs vom Vortag:
$5.84
Offen:
$5.94
24-Stunden-Volumen:
215.07K
Relative Volume:
0.19
Marktkapitalisierung:
$746.09M
Einnahmen:
$193.01M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-64.83
EPS:
-0.09
Netto-Cashflow:
$454.00K
1W Leistung:
+5.52%
1M Leistung:
+36.97%
6M Leistung:
+141.12%
1J Leistung:
-12.78%
Cytek Biosciences Inc Stock (CTKB) Company Profile
Firmenname
Cytek Biosciences Inc
Sektor
Branche
Telefon
(877) 922-9835
Adresse
47215 LAKEVIEW BOULEVARD, FREMONT
Vergleichen Sie CTKB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CTKB
Cytek Biosciences Inc
|
5.835 | 746.73M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
126.83 | 221.17B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.53 | 145.34B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
373.75 | 141.58B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
104.70 | 132.37B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
86.29 | 49.16B | 5.88B | 1.34B | 799.60M | 2.3489 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-31 | Herabstufung | Goldman | Buy → Sell |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-07-19 | Eingeleitet | Raymond James | Mkt Perform |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Bank of Montreal Can Boosts Stock Position in Cytek Biosciences, Inc. $CTKB - Defense World
Revenues Tell The Story For Cytek Biosciences, Inc. (NASDAQ:CTKB) As Its Stock Soars 43% - simplywall.st
Will Cytek Biosciences Inc. (8EQ) stock draw ESG focused fundsEarnings Recap Summary & Proven Capital Preservation Methods - newser.com
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity - Stock Titan
Officer/Dir Yan Acquires 15,908 Of Cytek BioSciences Inc [CTKB] - TradingView
Why Cytek Biosciences Inc. stock could be next big winnerJuly 2025 Update & AI Driven Stock Reports - newser.com
Is Cytek Biosciences Inc. (8EQ) stock a good hedge against inflationJuly 2025 Summary & High Conviction Buy Zone Alerts - newser.com
Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB) - Seeking Alpha
What technical charts say about Cytek Biosciences Inc. stockJuly 2025 Patterns & Reliable Momentum Entry Alerts - newser.com
Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo! Finance Canada
Why Cytek Biosciences Inc. (8EQ) stock is favored by hedge fundsAnalyst Upgrade & Daily Oversold Stock Bounce Ideas - newser.com
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumMarket Rally & Verified Chart Pattern Signals - newser.com
Check Out Cytek BioSciences Inc (CTKB)’s Trade Data Rather Than the Analysts’ Views - Setenews
What technical models suggest about Cytek Biosciences Inc.’s comeback - newser.com
Can Cytek Biosciences Inc. stock maintain growth trajectoryTrade Performance Summary & Free Real-Time Market Sentiment Alerts - newser.com
Does TIME Recognition Signal a Turning Point for Cytek Biosciences' (CTKB) Competitive Edge in Innovation? - Yahoo Finance
Cytek Biosciences (CTKB): Evaluating Valuation After TIME’s 2026 Growth Leaders Recognition and Recurring Revenue Momentum - Yahoo Finance
Understanding Cytek Biosciences Inc.’s price movementDollar Strength & High Conviction Investment Ideas - newser.com
Can a trend reversal in Cytek Biosciences Inc. lead to recoveryWatch List & Community Verified Swing Trade Signals - newser.com
Will Cytek Biosciences Inc. (8EQ) stock beat growth indexesEarnings Trend Report & Daily Profit Maximizing Tips - newser.com
How strong dollar benefits Cytek Biosciences Inc. (8EQ) stockPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
Is Cytek Biosciences Inc a good long term investmentEvening Star Patterns & View Live Stock Forecasts Instantly - earlytimes.in
Is Cytek Biosciences Inc. (8EQ) stock overpriced at current multiplesJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com
Cytek Biosciences explores cellular mechanisms driving inflammation - Traders Union
Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025 - ts2.tech
Finanzdaten der Cytek Biosciences Inc-Aktie (CTKB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cytek Biosciences Inc-Aktie (CTKB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):